Cargando…

Improvement of the Antibacterial Activity of Phage Lysin-Derived Peptide P87 through Maximization of Physicochemical Properties and Assessment of Its Therapeutic Potential

Phage lysins are a promising alternative to common antibiotic chemotherapy. However, they have been regarded as less effective against Gram-negative pathogens unless engineered, e.g., by fusing them to antimicrobial peptides (AMPs). AMPs themselves pose an alternative to antibiotics. In this work, A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vázquez, Roberto, Doménech-Sánchez, Antonio, Ruiz, Susana, Sempere, Julio, Yuste, Jose, Albertí, Sebastián, García, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598152/ https://www.ncbi.nlm.nih.gov/pubmed/36290106 http://dx.doi.org/10.3390/antibiotics11101448

Ejemplares similares

Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain
por: Vázquez, Roberto, et al.
Publicado: (2022)

Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials
por: Vázquez, Roberto, et al.
Publicado: (2018)

What’s in a Name? An Overview of the Proliferating Nomenclature in the Field of Phage Lysins
por: Vázquez, Roberto, et al.
Publicado: (2023)

P10 Phage-encoded lysins as promising antibacterials against uropathogenic Escherichia coli
por: Hanif, Sarmad, et al.
Publicado: (2023)

Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract
por: Domenech, Mirian, et al.
Publicado: (2018)

Bacteriophage lysins as antibacterials
por: Sharma, Umender, et al.
Publicado: (2017)

Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain
por: Sempere, Julio, et al.
Publicado: (2020)

1515. Nationwide trends of invasive pneumococcal disease in Spain for the period 2009-2019
por: de Miguel, Sara, et al.
Publicado: (2020)

Combination of Cefditoren and N-acetyl-l-Cysteine Shows a Synergistic Effect against Multidrug-Resistant Streptococcus pneumoniae Biofilms
por: Llamosí, Mirella, et al.
Publicado: (2022)

IE-7951. Evolución epidemiológica de los nuevos serotipos vacunales 22F y 33F de Streptococcus pneumoniae en España incluyendo el impacto de la pandemia por SARS-CoV-2
por: Sempere, J., et al.
Publicado: (2022)

Prediction of Antibacterial Activity from Physicochemical Properties of Antimicrobial Peptides
por: Melo, Manuel N., et al.
Publicado: (2011)

Mining of Gram-Negative Surface-Active Enzybiotic Candidates by Sequence-Based Calculation of Physicochemical Properties
por: Vázquez, Roberto, et al.
Publicado: (2021)

P26 Evaluating the antibacterial activity of recombinant phage-encoded lysin against drug-resistant uropathogenic Escherichia coli
por: Dhar, Sakshi, et al.
Publicado: (2023)

Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen
por: Vázquez, Roberto, et al.
Publicado: (2017)

Inhibition of Fibrinolysis by Streptococcal Phage Lysin(SM1)
por: Ji, Hyun Jung, et al.
Publicado: (2021)

In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide
por: Ma, Rui, et al.
Publicado: (2019)

Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages
por: Kim, Bi-o, et al.
Publicado: (2019)

Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa
por: Yang, Hang, et al.
Publicado: (2015)

Dynamic Motion and Communication in the Streptococcal C1 Phage Lysin, PlyC
por: Riley, Blake T., et al.
Publicado: (2015)

Development of Phage Lysins as Novel Therapeutics: A Historical Perspective
por: Fischetti, Vincent A.
Publicado: (2018)

Novel Phage Lysin Abp013 against Acinetobacter baumannii
por: Chu, Joash Jun Keat, et al.
Publicado: (2022)

IE-7925. Contribución de las vacunas antineumocócicas y la pandemia por SARS-CoV-2 en la evolución epidemiológica de la enfermedad neumocócica invasiva en España
por: de Miguel, S., et al.
Publicado: (2022)

Phage Therapy: Beyond Antibacterial Action
por: Górski, Andrzej, et al.
Publicado: (2018)

Synergy Between Two Chimeric Lysins to Kill Streptococcus pneumoniae
por: Vázquez, Roberto, et al.
Publicado: (2019)

IE-7950. Contribución de las vacunas conjugadas antineumocócicas y el SARS-CoV-2 a la resistencia a antibióticos en Streptococcus pneumoniae en España durante el periodo 2004-2020
por: Sempere, J., et al.
Publicado: (2022)

Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-l-cysteine and cysteamine
por: Sempere, Julio, et al.
Publicado: (2022)

PURIFICATION AND PHYSICAL PROPERTIES OF GROUP C STREPTOCOCCAL PHAGE-ASSOCIATED LYSIN
por: Fischetti, Vincent A., et al.
Publicado: (1971)

Phage Therapy, Lysin Therapy, and Antibiotics: A Trio Due to Come
por: G. Villa, Tomás, et al.
Publicado: (2020)

Phage lysin that specifically eliminates Clostridium botulinum Group I cells
por: Zhang, Zhen, et al.
Publicado: (2020)

Therapeutic potential of Bacillus phage lysin PlyB in ocular infections
por: Mursalin, Md Huzzatul, et al.
Publicado: (2023)

Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens
por: Shah, Sanket, et al.
Publicado: (2023)

Design combinations of evolved phage and antibiotic for antibacterial guided by analyzing the phage resistance of poorly antimicrobial phage
por: Xu, Zhenhe, et al.
Publicado: (2023)

Vaccination with LytA, LytC, or Pce of Streptococcus pneumoniae Protects against Sepsis by Inducing IgGs That Activate the Complement System
por: Corsini, Bruno, et al.
Publicado: (2021)

Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design
por: Vázquez, Roberto, et al.
Publicado: (2021)

The Transcription Factor ZNF395 Is Required for the Maximal Hypoxic Induction of Proinflammatory Cytokines in U87-MG Cells
por: Herwartz, Christine, et al.
Publicado: (2015)

Influence of Physicochemical Factors on Adsorption of Ten Shigella flexneri Phages
por: Tomat, David, et al.
Publicado: (2022)

EXM-87-09: 03/09/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-17: 19/11/87
por: Martucci, P, et al.
Publicado: (1987)

EXM-87-20: 17/12/87
por: Martucci, P, et al.
Publicado: (1988)

EXM-87-14: 22/10/87
por: Martucci, P, et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_cba6brskfjkkerh52qu01moi90